Cognitive function unaffected by combination HRT: study

The six month randomised controlled trial in 23 healthy postmenopausal women, conducted at Monash University, showed that continuous combined estradiol 1mg/drospirenone 2mg (E2D) did not affect overall cognitive performance in the treatment group compared with placebo.